Contemporary Evidence In Sinonasal Malignancy Treatment 2026
09-11, 08:00–09:00 (Europe/Istanbul), Rhinology 1 (ICC - B2 Floor - Beyazıt)

Contemporary evidence in sinonasal malignancy treatment 2026

Session Chair Session Chair
Moderator Moderator

Edward Kuan, MD, MBA, FARS is Division Chief of Rhinology and Skull Base Surgery, co-director of the Comprehensive Skull Base Program, and Professor of Otolaryngology-Head and Neck Surgery and Neurological Surgery at the University of California, Irvine. He received his medical degree from UC Irvine. He then completed residency training in otolaryngology-head and neck surgery at UCLA, followed by fellowship training in rhinology and skull base surgery at the University of Pennsylvania.

His research interests include evidence-based skull base reconstruction and biological basis of and management principles for sinonasal tumors. He has published more than 350 peer-reviewed original articles, reviews, and book chapters in the highest-impact otolaryngology and neurosurgery journals and is a regular invited speaker for both clinical topics and his research nationally and internationally. He is actively involved in the American Rhinologic Society, serving on the Board of Directors as Education Coordinator; North American Skull Base Society; and Triological Society, where he is a fellow member.

He is the primary editor of a textbook on skull base reconstruction and is the primary editor of the International Consensus Statement on Allergy and Rhinology - Sinonasal Tumors document. He also serves as an associate editor of International Forum of Allergy & Rhinology and American Journal of Rhinology & Allergy, and also on the editorial board of Rhinology.

This speaker also appears in:

Prof. Dr. Cem MEÇO, FEBORL-HNS, Senior FEBORL-HNS (Hon.)

Professor and Past Chairman, Ankara University Medical School, Department of ORL-HNS, Ankara, Türkiye

Professor, Salzburg Paracelsus Medical University, Department of ORL-HNS, Salzburg, Austria

Adjunct Clinical Professor, Cornell University, Weill Cornell Medical College, Department of Otolaryngology - Head and Neck Surgery, New York, NY, USA

President and Chairman, European Board Examination in Otorhinolaryngology - Head and Neck Surgery (EBEORL-HNS)

Past President and Presidential Council Member, Confederation of European Otorhinolaryngology - Head and Neck Surgery (CEORL-HNS)

Executive Committee Member, European Skull Base Society

Chair-elect, International Advisory Board, American Academy of Otolaryngology - Head and Neck Surgery

Advisory Board Member, UEMS ORL Section

Advisory Board Member, European Rhinologic Society

Executive Committee Member, Turkish Skull Base Society

Member-at-Large, International Steering Committee, American Academy of Otolaryngology - Head and Neck Surgery

This speaker also appears in:

Dr. Singh is a Professor of Surgery in the Division of Otolaryngology-Head and Neck Surgery and a Professor of Neurosurgery in the Department of Neurosurgery at the George Washington University Medical Center. 

He earned his B.S. from Massachusetts Institute of Technology (MIT) and an M.D. from Cornell University, where he served as the class president for four years and was awarded the prestigious Ben H. Kean International Fellowship, and the Charles Horn Prize for service to the medical community. He completed his residency in Otolaryngology-Head and Neck Surgery from the University of Rochester, Strong Memorial Hospital and an advanced fellowship in rhinology, endoscopic sinus surgery & skull base surgery at Cornell University, New York Presbyterian Hospital.

Dr. Singh’s research interests include minimally invasive endoscopic sinus and skull base surgery for chronic sinusitis, sinonasal tumors, and anterior skull base brain tumors. He has served as the primary investigator for 6 research grants, authored over 45 peer-reviewed publications, 20 book chapters, and co-authored a book on endoscopic sinus and skull base surgery. He regularly lectures at national and international forums on rhinology and anterior skull base surgery. He has been featured on NBC, ABC, and in the Washington Post. He was the founding course director of the nationally recognized Cherry Blossom Otolaryngology Update, a continuing medical education event for students, residents, and practicing Otolaryngologists.

Ehab Hanna, M.D., FACS, is an internationally recognized head and neck surgeon and expert in the treatment of patients with skull base tumors and head and neck cancer. Dr. Hanna is currently a Professor and Vice Chair of the Department of Head and Neck Surgery with a joint appointment in the Department of Neurosurgery, MD Anderson Cancer Center. He also serves as an Adjunct Professor of Otolaryngology and Head and Neck Surgery at Baylor College of Medicine. He served as the medical director of the Multidisciplinary Head and Neck Center for 20 years (2004-2023) and is currently the director of the Skull Base Tumor program. For the last 15 years, Dr. Hanna has consistently been named one of America's Best Doctors and Top Doctors in Cancer. In addition to patient care, Dr. Hanna is actively engaged in clinical and translational research with emphasis on skull base tumors. He authored over 350 publications, invited articles, book chapters, and editorials. He co-edited several major textbooks on Cancer of the Head and Neck, Cancer of the Larynx, and Comprehensive Management of Skull Base Tumors. He served as the Editor-in-Chief of the journal of Head & Neck for 15 years from 2007 to 2022. Dr. Hanna served as the President of the North American Skull Base Society (2013-2014) and the President of the American Head and Neck Society (2018-2019). He is currently the Secretary General of the International Federation of Head & Neck Oncologic Societies, the largest organization in the world for Head and Neck Oncology.

This speaker also appears in:

Dr. Ian Witterick is Surgeon-in-Chief at Sinai Health in Toronto and Professor in the Department of Otolaryngology–Head & Neck Surgery (OHNS) at the University of Toronto. He previously served as Chair of the Department of OHNS at the University of Toronto, completing a 10-year term in 2022.

Dr. Witterick has held numerous national and international leadership positions, including President of the Canadian Society of Otolaryngology–Head & Neck Surgery and the North American Skull Base Society. He served as Chair of the Skull Base Section for the American Head and Neck Society and is a member of the Steering Committee for the World Congress on Thyroid Cancer.

Dr. Witterick has published extensively and is a frequent invited speaker nationally and internationally in the fields of head and neck oncology, rhinology, and anterior skull base surgery.

This speaker also appears in: